Abstract:Enya Daynes, 1, 2 Linzy Houchen-Wolloff, 1, 2 Amy C Barradell, 1, 2 Neil J Greening, 1, 2 Sally J Singh 1, 2 1 Leicester NIHR Biomedical Research Centre Respiratory, Glenfield Hospital, Leicester, UK; 2 Department of Respiratory Sciences, University of Leicester, Leicester, UK Correspondence: Enya Daynes, NIHR Leicester Biomedical Research Centre- Respiratory, Glenfield Hospital, Groby Road, Leicester, UK, Email Introduction: The High Frequency Airway Oscillating device (HFAO) was developed to help patients with COPD feel less breathless through flow resistive respiratory muscle training and fixed rate oscillations. Previous work has demonstrated that this device can improve inspiratory muscle strength over and above a sham device. Both groups improved their breathlessness and preserved clinical benefits though there were no statistically significant differences seen over and above the sham device. It is important to understand patient perceptions of using a device and how this may influence their treatment and therefore a qualitative analysis was conducted to understand participant experiences of a HFAO device. Methods: This was an exploratory qualitative analysis involving participants recruited to the Training to Improve Dyspnoea (TIDe) study. Participants completed a satisfaction survey and were invited to take part in a focus group. Focus groups were conducted by a researcher independent to the randomised controlled trial. Data was analysed independently by two researchers using inductive thematic analysis, and themes/sub-themes were agreed jointly. Data is presented in themes and sub themes and triangulated with survey response data. Results: Fourteen participants were recruited to two focus groups (71% male, mean [SD] age 64[9] years). The key themes were patient selection, device use, and investment. Patient selection explores the disease characteristics, emotional impact and management of care. Device use explores the device prescription and usage, routine and lifestyle and effectiveness. Investment covers accessibility, understanding, benefits vs participation and overall perceptions of the device. Conclusion: This research demonstrates the complexity of device interventions and that key considerations should be given to patient selection, the device use itself and, the time and cost investment required for participants to successfully implement the device into daily life. Keywords: COPD, breathlessness, qualitative Chronic Obstructive Pulmonary Disease (COPD) is a disease of the small airways that leads to debilitating breathlessness, which can impact on function and quality of life. 1 Other symptoms such as excessive sputum and cough can co-exist in patients with COPD. 2 Breathlessness is a multifactorial symptom with various pathophysiologies such as inspiratory muscle weakness and inefficiency. Changes in breathing mechanics and an increased work of breathing results in an inability to meet the respiratory demands leading to intolerable breathlessness. 3 The inspiratory muscles are often placed on a stretch due to hyperinflation and have a reduced capacity; this can cause or contribute to breathlessness for some patients. Respiratory muscle training has been used to reduce breathlessness in some groups of patients, particularly those that have a baseline maximal inspiratory pressure of ≤60cmH 2 O. 3,4 There are a variety of different inspiratory muscle training devices that have differing benefits and research has not yet identified which patients have the greatest clinical benefit. 4 Expiratory muscle training or combined respiratory muscle training has been shown to improve breathlessness compared to a control group, however, there is less supporting evidence. 5 Devices have also shown promise in managing excessive sputum and cough through oscillatory positive expiratory pressure, demonstrating significant improvements in sputum volume, cough and quality of life. 6,7 The High Frequency Airway Oscillations (HFAO) (Aerosure ©) device utilises for inspiratory and expiratory muscle training to target breathlessness, and airway oscillations that may improve sputum and quality of life. The HFAO device has demonstrated improvements in respiratory muscle strength and breathlessness in healthy volunteers through flow resistance. 8 The use of HFAO in patients with COPD (the TIDe study) did not demonstrate clinical benefits in breathlessness above a sham, however both groups did improve their breathlessness above established Minimal Clinical Important Differences. The HFAO device demonstrated improves inspirato -Abstract Truncated-

Domiciliary nasal high flow therapy for breathlessness; chronic obstructive pulmonary disease (COPD)

High-flow nasal cannula during pulmonary rehabilitation for people with chronic obstructive pulmonary disease: A systematic review and meta-analysis

The effect of domiciliary high flow nasal cannula treatment on dyspnea and walking distance in patients with interstitial lung disease – A pilot study

The Training to Improve Dyspnoea Study- Patient Experiences of Using a High Frequency Airway Oscillating Device

Effectiveness, Adherence and Safety of Home High Flow Nasal Cannula in Chronic Respiratory Disease and Respiratory Insufficiency: A Systematic Review

Nasal High Flow for Stable Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

The effectiveness, adherence and safety of home high flow nasal cannula in patients with chronic respiratory disease and respiratory insufficiency: a systematic review

Long-Term High-Flow Nasal Therapy in Patients with Bronchiectasis of Different Severity: A Retrospective Cohort Study

Clinical Evidence of Nasal High-Flow Therapy in Chronic Obstructive Pulmonary Disease Patients

High-flow nasal cannula improves respiratory impedance evaluated by impulse oscillometry in chronic obstructive pulmonary disease patients: a randomised controlled trial

Delivery of Aerosolized Bronchodilators by High-Flow Nasal Cannula During COPD Exacerbation

Nasal high flow or noninvasive ventilation? navigating hypercapnic COPD exacerbation treatment: A randomized noninferiority clinical trial

Effect of high-flow nasal cannula at different flow rates on diaphragmatic function in subjects recovering from an acute exacerbation of COPD: a physiological prospective pilot study

Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial

High-flow nasal cannula therapy for initial oxygen administration in acute hypercapnic respiratory failure: study protocol of randomised controlled unblinded trial

High-Flow Nasal Cannula for Chronic Obstructive Pulmonary Disease with Acute Compensated Hypercapnic Respiratory Failure: A Randomized, Controlled Trial

High-flow nasal cannula and in-line aerosolised bronchodilator delivery during severe exacerbation of asthma in adults: a feasibility observational study

Effectiveness of a long-term home-based exercise training in COPD patients: The HOMEX-2 RCT

COPD patients experience with long-term non-invasive ventilation: A qualitative study

Effects of high-flow nasal cannula oxygen therapy for patients with acute exacerbation of chronic obstructive pulmonary disease in combination with type II respiratory failure

A multidisciplinary, non-pharmacologic intervention improves breathlessness in COPD: An RCT.